HROW Q4 2020 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q4 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$15M+15.8% YoY

Gross Profit

$11M73.0% margin

Operating Income

$3M18.0% margin

Net Income

$1M7.9% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

+1.4%

Cash Flow

Operating Cash Flow

-$566,000

Free Cash Flow

-$669,000

Stock-Based Comp.

$780,000

Balance Sheet

Total Assets

$57M

Total Liabilities

$31M

Stockholders' Equity

$27M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$13M	+15.8%
Gross Profit	$11M	$9M	+17.9%
Operating Income	$3M	$926,000	+183.6%
Net Income	$1M	$3M	-56.8%

Revenue Segments

Other Revenues

$360,000100%